Word abonnee en neem Beursduivel Premium
Rode planeet als pijlen grid met hoorntjes Beursduivel

Royal Bank Of Scotland Terug naar discussie overzicht

RBS week 43

1 Post
| Omlaag ↓
  1. forum rang 6 benbelegger 22 oktober 2013 08:25
    Gisteren een sterke daling , toekomst wisselvallig:

    uit The Guardian:

    Despite markets continuing to move higher in the wake of the recent US debt deal, Royal Bank of Scotland was under the cosh once more.

    Its shares fell 19.6p or 5% to 353.1p amid growing talk the government would split it into a good and bad bank, with many in the City believing this could be to the detriment of minority shareholders. On top of that, the banking sector came under pressure after JP Morgan reportedly made a tentative $13bn settlement relating to bad mortgage loans sold before the 2008 crisis. Others may have to follow suit. Nomura said:

    We think it is becoming more likely that the good bank/bad bank review will result in significant change for RBS. A decision is said to be imminent in the next few weeks and several options are being considered: 1) setting up a bad bank inside RBS to be run by an independent team; 2) setting up a bad bank inside RBS, in a model similar to that of UBS, which had more support from the central bank; 3) the final option would be the taxpayer-backed bad bank for the assets, similar to the solution from the Swedish government in the 1990s. We continue to believe that minority shareholders have much to lose from an unfavourable outcome of the review with the government maintaining considerable leverage over the minorities.

    On the US mortgage securities, Nomura said there was a material risk for RBS:

    RBS was involved in the sale of around $32bn of the MBS securities under scrutiny (similar to JP Morgan's $33bn). The largest Federal Housing Finance Agency (FHFA) suit is in Connecticut courts rather than New York, where more of the harsher settlements have been imposed and losses on RBS portfolios experienced by the FHFA have been said to be lower. However, due to the legal uncertainties and the large settlements discussed by the press, we see this as a material tail risk to the group. Potential capital release from [the sale of US subsidiary] Citizens helps in this context to plug any holes, though we don't see it as a means to buy back shares.
1 Post
|Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Beursduivel.be

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 466 7.120
AB InBev 2 5.538
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.582 52.177
ABO-Group 1 25
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 267
Accsys Technologies 23 10.859
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 192
Adecco 1 1
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 14 17.840
Aedifica 3 926
Aegon 3.258 323.077
AFC Ajax 538 7.091
Affimed NV 2 6.305
ageas 5.844 109.905
Agfa-Gevaert 14 2.063
Ahold 3.538 74.353
Air France - KLM 1.025 35.293
AIRBUS 1 12
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 467 13.050
Alfen 16 25.291
Allfunds Group 4 1.517
Almunda Professionals (vh Novisource) 651 4.251
Alpha Pro Tech 1 17
Alphabet Inc. 1 422
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.486 114.826
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.837 243.916
AMG 971 134.365
AMS 3 73
Amsterdam Commodities 305 6.745
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 496
Antonov 22.632 153.605
Aperam 92 15.059
Apollo Alternative Assets 1 17
Apple 5 386
Arcadis 252 8.806
Arcelor Mittal 2.034 320.990
Archos 1 1
Arcona Property Fund 1 287
arGEN-X 17 10.355
Aroundtown SA 1 221
Arrowhead Research 5 9.751
Ascencio 1 28
ASIT biotech 2 697
ASMI 4.108 39.614
ASML 1.766 110.192
ASR Nederland 21 4.512
ATAI Life Sciences 1 7
Atenor Group 1 522
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 32 13.941
Axsome Therapeutics 1 177
Azelis Group 1 67
Azerion 7 3.449

Macro & Bedrijfsagenda

  1. 31 maart

    1. Inkoopmanagersindex industrie en diensten maart (Chi)
    2. Importprijzen februari (Dld)
    3. Detailhandelsverkopen februari (Dld)
    4. Inflatie maart vlpg (Dld)
    5. Inkoopmanagersindex Chicago maart (VS)
  2. 01 april

    1. Tankan index eerste kwartaal (Jap)
    2. Inkoopmanagersindex industrie maart def. (Jap)
    3. Inkoopmanagersindex industrie Caixin maart (Chi)
    4. Reserve Bank of Australia rentebesluit (Aus)
    5. Omzet detailhandel februari (NL)
de volitaliteit verwacht indicator betekend: Market moving event/hoge(re) volatiliteit verwacht